Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1985 Sep;54(3):234–242. doi: 10.1136/hrt.54.3.234

Drug treatment of heart failure.

C T Dollery, L Corr
PMCID: PMC481887  PMID: 3899148

Full text

PDF
234

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnold S. B., Byrd R. C., Meister W., Melmon K., Cheitlin M. D., Bristow J. D., Parmley W. W., Chatterjee K. Long-term digitalis therapy improves left ventricular function in heart failure. N Engl J Med. 1980 Dec 18;303(25):1443–1448. doi: 10.1056/NEJM198012183032503. [DOI] [PubMed] [Google Scholar]
  2. Aronow W. S., Greenfield R. S., Alimadadian H., Danahy D. T. Effect of the vasodilator trimazosin versus placebo on exercise performance in chronic left ventricular failure. Am J Cardiol. 1977 Nov;40(5):789–793. doi: 10.1016/0002-9149(77)90198-9. [DOI] [PubMed] [Google Scholar]
  3. Ashutosh K., Mead G., Dunsky M. Early effects of oxygen administration and prognosis in chronic obstructive pulmonary disease and cor pulmonale. Am Rev Respir Dis. 1983 Apr;127(4):399–404. doi: 10.1164/arrd.1983.127.4.399. [DOI] [PubMed] [Google Scholar]
  4. Astrand P. O. Quantification of exercise capability and evaluation of physical capacity in man. Prog Cardiovasc Dis. 1976 Jul-Aug;19(1):51–67. doi: 10.1016/0033-0620(76)90008-6. [DOI] [PubMed] [Google Scholar]
  5. BAYLISS R. I., MARRACK D., PIRKIS J., REES J. R., ZILVA J. F. Chlorothiazide: an oral diuretic. Lancet. 1958 Jan 18;1(7012):120–124. doi: 10.1016/s0140-6736(58)90610-x. [DOI] [PubMed] [Google Scholar]
  6. Braunwald E. Vasodilator therapy--a physiologic approach to the treatment of heart failure. N Engl J Med. 1977 Aug 11;297(6):331–333. doi: 10.1056/NEJM197708112970609. [DOI] [PubMed] [Google Scholar]
  7. Bruce R. A. Exercise testing for evaluation of ventricular function. N Engl J Med. 1977 Mar 24;296(12):671–675. doi: 10.1056/NEJM197703242961206. [DOI] [PubMed] [Google Scholar]
  8. Bruschke A. V., Proudfit W. L., Sones F. M., Jr Progress study of 590 consecutive nonsurgical cases of coronary disease followed 5-9 years. II. Ventriculographic and other correlations. Circulation. 1973 Jun;47(6):1154–1163. doi: 10.1161/01.cir.47.6.1154. [DOI] [PubMed] [Google Scholar]
  9. COHEN T. Hypokalemic muscle paralysis associated with administration of chlorothiazide. J Am Med Assoc. 1959 Aug 22;170(17):2083–2085. doi: 10.1001/jama.1959.63010170003010a. [DOI] [PubMed] [Google Scholar]
  10. COUNIHAN T. B., EVANS B. M., MILNE M. D. Observations on the pharmacology of the carbonic anhydrase inhibitor diamox. Clin Sci. 1954 Nov;13(4):583–598. [PubMed] [Google Scholar]
  11. Cleland J. G., Dargie H. J., Hodsman G. P., Ball S. G., Robertson J. I., Morton J. J., East B. W., Robertson I., Murray G. D., Gillen G. Captopril in heart failure. A double blind controlled trial. Br Heart J. 1984 Nov;52(5):530–535. doi: 10.1136/hrt.52.5.530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Colucci W. S., Wynne J., Holman B. L., Braunwald E. Long-term therapy of heart failure with prazosin: a randomized double blind trial. Am J Cardiol. 1980 Feb;45(2):337–344. doi: 10.1016/0002-9149(80)90656-6. [DOI] [PubMed] [Google Scholar]
  13. Conradson T. B., Rydén L., Ahlmark G., Saetre H., Persson S., Nyquist O., Wernersson B. Clinical efficacy of hydralazine in chronic heart failure: one-year double-blind placebo-controlled study. Am Heart J. 1984 Oct;108(4 Pt 1):1001–1006. doi: 10.1016/0002-8703(84)90467-8. [DOI] [PubMed] [Google Scholar]
  14. Cowley A. J., Rowley J. M., Stainer K. L., Hampton J. R. Captopril therapy for heart failure. A placebo controlled study. Lancet. 1982 Oct 2;2(8301):730–732. doi: 10.1016/s0140-6736(82)90920-5. [DOI] [PubMed] [Google Scholar]
  15. DOLLERY C. T., PARRY E. H., YOUNG D. S. DIURETIC AND HYPOTENSIVE PROPERTIES OF ETHACRYNIC ACID: A COMPARISON WITH HYDROCHLOROTHIAZIDE. Lancet. 1964 May 2;1(7340):947–952. doi: 10.1016/s0140-6736(64)91742-8. [DOI] [PubMed] [Google Scholar]
  16. DiBianco R., Shabetai R., Silverman B. D., Leier C. V., Benotti J. R. Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study. J Am Coll Cardiol. 1984 Nov;4(5):855–866. doi: 10.1016/s0735-1097(84)80044-3. [DOI] [PubMed] [Google Scholar]
  17. Dobbs S. M., Kenyon W. I., Dobbs R. J. Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients. Br Med J. 1977 Mar 19;1(6063):749–752. doi: 10.1136/bmj.1.6063.749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Engler R., Ray R., Higgins C. B., McNally C., Buxton W. H., Bhargava V., Shabetai R. Clinical assessment and follow-up of functional capacity in patients with chronic congestive cardiomyopathy. Am J Cardiol. 1982 Jun;49(8):1832–1837. doi: 10.1016/0002-9149(82)90199-0. [DOI] [PubMed] [Google Scholar]
  19. Evans J. R., Pacht K., Huss P., Unverferth D. V., Bashore T. M., Leier C. V. Chronic oral amrinone therapy in congestive heart failure: a double-blind placebo-controlled withdrawal study. Int J Clin Pharmacol Res. 1984;4(1):9–18. [PubMed] [Google Scholar]
  20. FORD R. V. Clinical pharmacology of diuretic agents with special reference to chlorothiazide (diuril). Dis Chest. 1960 Apr;37:418–429. doi: 10.1378/chest.37.4.418. [DOI] [PubMed] [Google Scholar]
  21. FREIS E. D. Treatment of hypertension with chlorothiazide. J Am Med Assoc. 1959 Jan 10;169(2):105–108. doi: 10.1001/jama.1959.03000190007002. [DOI] [PubMed] [Google Scholar]
  22. Fleg J. L., Gottlieb S. H., Lakatta E. G. Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm. Am J Med. 1982 Aug;73(2):244–250. doi: 10.1016/0002-9343(82)90186-3. [DOI] [PubMed] [Google Scholar]
  23. Franciosa J. A., Cohn J. N. Immediate effects of hydralazine-isosorbide dinitrate combination on exercise capacity and exercise hemodynamics in patients with left ventricular failure. Circulation. 1979 Jun;59(6):1085–1091. doi: 10.1161/01.cir.59.6.1085. [DOI] [PubMed] [Google Scholar]
  24. Franciosa J. A. Exercise testing in chronic congestive heart failure. Am J Cardiol. 1984 May 15;53(10):1447–1450. doi: 10.1016/s0002-9149(84)91041-5. [DOI] [PubMed] [Google Scholar]
  25. Franciosa J. A., Goldsmith S. R., Cohn J. N. Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure. Am J Med. 1980 Oct;69(4):559–566. doi: 10.1016/0002-9343(80)90468-4. [DOI] [PubMed] [Google Scholar]
  26. Franciosa J. A., Mikulic E., Cohn J. N., Jose E., Fabie A. Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure. Circulation. 1974 Nov;50(5):1020–1024. doi: 10.1161/01.cir.50.5.1020. [DOI] [PubMed] [Google Scholar]
  27. Franciosa J. A., Park M., Levine T. B. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol. 1981 Jan;47(1):33–39. doi: 10.1016/0002-9149(81)90286-1. [DOI] [PubMed] [Google Scholar]
  28. Franciosa J. A., Weber K. T., Levine T. B., Kinasewitz G. T., Janicki J. S., West J., Henis M. M., Cohn J. N. Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo. Am Heart J. 1982 Sep;104(3):587–594. doi: 10.1016/0002-8703(82)90231-9. [DOI] [PubMed] [Google Scholar]
  29. Franciosa J. A., Wilen M., Ziesche S., Cohn J. N. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 1983 Mar 1;51(5):831–836. doi: 10.1016/s0002-9149(83)80141-6. [DOI] [PubMed] [Google Scholar]
  30. Franciosa J. A., Ziesche S., Wilen M. Functional capacity of patients with chronic left ventricular failure. Relationship of bicycle exercise performance to clinical and hemodynamic characterization. Am J Med. 1979 Sep;67(3):460–466. doi: 10.1016/0002-9343(79)90794-0. [DOI] [PubMed] [Google Scholar]
  31. Furberg C. D., Hawkins C. M., Lichstein E. Effect of propranolol in postinfarction patients with mechanical or electrical complications. Circulation. 1984 Apr;69(4):761–765. doi: 10.1161/01.cir.69.4.761. [DOI] [PubMed] [Google Scholar]
  32. GROSSMAN J., WESTON R. E., LEHMAN R. A., HALPERIN J. P., ULLMANN T. D., LEITER L. Urinary and fecal excretion of mercury in man following administration of mercurial diuretics. J Clin Invest. 1951 Nov;30(11):1208–1220. doi: 10.1172/JCI102540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. GRUNDY H. M., SIMPSON S. A., TAIT J. F. Isolation of a highly active mineralocorticoid from beef adrenal extract. Nature. 1952 May 10;169(4306):795–796. doi: 10.1038/169795a0. [DOI] [PubMed] [Google Scholar]
  34. HANLEY T., PLATTS M. M. Acetazolamide (diamox) in the treatment of congestive heart-failure. Lancet. 1956 Apr 7;270(6919):357–359. doi: 10.1016/s0140-6736(56)90105-2. [DOI] [PubMed] [Google Scholar]
  35. HUTCHEON D. E., MEHTA D., ROMANO A. DIURETIC ACTION OF FUROSEMIDE. Arch Intern Med. 1965 May;115:542–546. doi: 10.1001/archinte.1960.03860170024006. [DOI] [PubMed] [Google Scholar]
  36. Hamby R. I. Primary myocardial disease. A prospective clinical and hemodynamic evaluation in 100 patients. Medicine (Baltimore) 1970 Jan;49(1):55–78. [PubMed] [Google Scholar]
  37. Higginbotham M. B., Morris K. G., Bramlet D. A., Coleman R. E., Cobb F. R. Long-term ambulatory therapy with prazosin versus placebo for chronic heart failure: relation between clinical response and left ventricular function at rest and during exercise. Am J Cardiol. 1983 Oct 1;52(7):782–788. doi: 10.1016/0002-9149(83)90415-0. [DOI] [PubMed] [Google Scholar]
  38. Johnston G. D., McDevitt D. G. Is maintenance digoxin necessary in patients with sinus rhythm? Lancet. 1979 Mar 17;1(8116):567–570. doi: 10.1016/s0140-6736(79)91002-x. [DOI] [PubMed] [Google Scholar]
  39. Kersting F., Follath F., Moulds R., Mucklow J., McCloy R., Sheares J., Dollery C. A comparison of cardiovascular effects of dobutamine and isoprenaline after open heart surgery. Br Heart J. 1976 Jun;38(6):622–626. doi: 10.1136/hrt.38.6.622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Knight R. K., Miall P. A., Hawkins L. A., Dacombe J., Edwards C. R., Hamer J. Relation of plasma aldosterone concentration to diuretic treatment in patients with severe heart disease. Br Heart J. 1979 Sep;42(3):316–325. doi: 10.1136/hrt.42.3.316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Lee D. C., Johnson R. A., Bingham J. B., Leahy M., Dinsmore R. E., Goroll A. H., Newell J. B., Strauss H. W., Haber E. Heart failure in outpatients: a randomized trial of digoxin versus placebo. N Engl J Med. 1982 Mar 25;306(12):699–705. doi: 10.1056/NEJM198203253061202. [DOI] [PubMed] [Google Scholar]
  42. Leier C. V., Huss P., Lewis R. P., Unverferth D. V. Drug-induced conditioning in congestive heart failure. Circulation. 1982 Jun;65(7):1382–1387. doi: 10.1161/01.cir.65.7.1382. [DOI] [PubMed] [Google Scholar]
  43. Leier C. V., Huss P., Magorien R. D., Unverferth D. V. Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure. Circulation. 1983 Apr;67(4):817–822. doi: 10.1161/01.cir.67.4.817. [DOI] [PubMed] [Google Scholar]
  44. Liang C. S., Sherman L. G., Doherty J. U., Wellington K., Lee V. W., Hood W. B., Jr Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine. Circulation. 1984 Jan;69(1):113–119. doi: 10.1161/01.cir.69.1.113. [DOI] [PubMed] [Google Scholar]
  45. MYERSON R. M., STOUT R. E., FORTE A. L. Acetazolamide and chlorothiazide in the treatment of ascites due to cirrhosis of the liver. N Engl J Med. 1959 Jan 1;260(1):28–30. doi: 10.1056/NEJM195901012600106. [DOI] [PubMed] [Google Scholar]
  46. Mason D. T. Symposium on vasodilator and inotropic therapy of heart failure. Symposium perspective. Am J Med. 1978 Jul;65(1):101–105. doi: 10.1016/0002-9343(78)90699-x. [DOI] [PubMed] [Google Scholar]
  47. Mason D. T., Zelis R., Longhurst J., Lee G. Cardiocirculatory responses to muscular exercise in congestive heart failure. Prog Cardiovasc Dis. 1977 May-Jun;19(6):475–489. doi: 10.1016/0033-0620(77)90011-1. [DOI] [PubMed] [Google Scholar]
  48. Massie B., Ports T., Chatterjee K., Parmley W., Ostland J., O'Young J., Haughom F. Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements. Circulation. 1981 Feb;63(2):269–278. doi: 10.1161/01.cir.63.2.269. [DOI] [PubMed] [Google Scholar]
  49. McHaffie D., Purcell H., Mitchell-Heggs P., Guz A. The clinical value of digoxin in patients with heart failure and sinus rhythm. Q J Med. 1978 Oct;47(188):401–419. [PubMed] [Google Scholar]
  50. McKee P. A., Castelli W. P., McNamara P. M., Kannel W. B. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971 Dec 23;285(26):1441–1446. doi: 10.1056/NEJM197112232852601. [DOI] [PubMed] [Google Scholar]
  51. Mitchell J. H., Blomqvist G. Maximal oxygen uptake. N Engl J Med. 1971 May 6;284(18):1018–1022. doi: 10.1056/NEJM197105062841809. [DOI] [PubMed] [Google Scholar]
  52. Nicholls M. G., Espiner E. A., Donald R. A., Hughes H. Aldosterone and its regulation during diuresis in patients with gross congestive heart failure. Clin Sci Mol Med. 1974 Oct;47(4):301–315. doi: 10.1042/cs0470301. [DOI] [PubMed] [Google Scholar]
  53. PITTS R. F. Some reflections on mechanisms of action of diuretics. Am J Med. 1958 May;24(5):745–763. doi: 10.1016/0002-9343(58)90378-4. [DOI] [PubMed] [Google Scholar]
  54. Patterson J. A., Naughton J., Pietras R. J., Gunnar R. M. Treadmill exercise in assessment of the functional capacity of patients with cardiac disease. Am J Cardiol. 1972 Nov;30(7):757–762. doi: 10.1016/0002-9149(72)90151-8. [DOI] [PubMed] [Google Scholar]
  55. RELMAN A. S., LEAF A., SCHWARTZ W. B. Oral administration of a potent carbonic anhydrase inhibitor (Diamox). II. Its use as a diuretic in patients with severe congestive heart failure. N Engl J Med. 1954 May 13;250(19):800–804. doi: 10.1056/NEJM195405132501902. [DOI] [PubMed] [Google Scholar]
  56. RICHARDS D. W. The contributions of right heart catheterization to physiology and medicine, with some observations on the physiopathology of pulmonary heart disease. Am Heart J. 1957 Aug;54(2):161–171. doi: 10.1016/0002-8703(57)90143-6. [DOI] [PubMed] [Google Scholar]
  57. Rubin S. A., Chatterjee K., Gelberg H. J., Ports T. A., Brundage B. H., Parmley W. W. Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure. Am J Cardiol. 1979 Apr;43(4):810–815. doi: 10.1016/0002-9149(79)90082-1. [DOI] [PubMed] [Google Scholar]
  58. SHERLOCK S., READ A. E., LAIDLAW J. L., HASLAM R. Chlorothiazide in liver disease. Ann N Y Acad Sci. 1958 Feb 3;71(4):430–437. doi: 10.1111/j.1749-6632.1958.tb46770.x. [DOI] [PubMed] [Google Scholar]
  59. SLATER J. D., NABARRO J. D. Clinical experience with chlorothiazide. Lancet. 1958 Jan 18;1(7012):124–127. doi: 10.1016/s0140-6736(58)90611-1. [DOI] [PubMed] [Google Scholar]
  60. STOKES W. A NEW EFFECTIVE DIURETIC--LASIX. Br Med J. 1964 Oct 10;2(5414):910–914. doi: 10.1136/bmj.2.5414.910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Shugoll G. I., Bowen P. J., Moore J. P., Lenkin M. L. Follow-up observations and prognosis in primary myocardial disease. Arch Intern Med. 1972 Jan;129(1):67–72. [PubMed] [Google Scholar]
  62. Starling E. H. On the Absorption of Fluids from the Connective Tissue Spaces. J Physiol. 1896 May 5;19(4):312–326. doi: 10.1113/jphysiol.1896.sp000596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Stason W. B., Cannon P. J., Heinemann H. O., Laragh J. H. Furosemide. A clinical evaluation of its diuretic action. Circulation. 1966 Nov;34(5):910–920. doi: 10.1161/01.cir.34.5.910. [DOI] [PubMed] [Google Scholar]
  64. Swan H. J., Ganz W., Forrester J., Marcus H., Diamond G., Chonette D. Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med. 1970 Aug 27;283(9):447–451. doi: 10.1056/NEJM197008272830902. [DOI] [PubMed] [Google Scholar]
  65. Szlachcic J., Massie B. M., Kramer B. L., Topic N., Tubau J. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol. 1985 Apr 1;55(8):1037–1042. doi: 10.1016/0002-9149(85)90742-8. [DOI] [PubMed] [Google Scholar]
  66. Tunstall-Pedoe H. Changing digoxin potency and cardiac mortality in England and Wales 1968-76. Br Heart J. 1985 Sep;54(3):243–247. doi: 10.1136/hrt.54.3.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Unverferth D. V., Magorien R. D., Moeschberger M. L., Baker P. B., Fetters J. K., Leier C. V. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol. 1984 Jul 1;54(1):147–152. doi: 10.1016/0002-9149(84)90320-5. [DOI] [PubMed] [Google Scholar]
  68. VEREL D., STENTIFORD N. H., RAHMAN F., SAYNOR R. A CLINICAL TRIAL OF FRUSEMIDE. Lancet. 1964 Nov 21;2(7369):1088–1089. doi: 10.1016/s0140-6736(64)92609-1. [DOI] [PubMed] [Google Scholar]
  69. WALSH A. C., MOYES A. INTRACTABLE CONGESTIVE HEART FAILURE SUCCESSFULLY TREATED WITH SOUTHEY TUBES. Can Med Assoc J. 1964 Jun 13;90:1375–1376. [PMC free article] [PubMed] [Google Scholar]
  70. WENER J., KNIGHT A. Some observations on a new oral diuretic, mictine. Can Med Assoc J. 1957 Jun 1;76(11):952–954. [PMC free article] [PubMed] [Google Scholar]
  71. Weber K. T., Andrews V., Janicki J. S. Cardiotonic agents in the management of chronic cardiac failure. Am Heart J. 1982 Apr;103(4 Pt 2):639–649. doi: 10.1016/0002-8703(82)90469-0. [DOI] [PubMed] [Google Scholar]
  72. Weber K. T., Kinasewitz G. T., West J. S., Janicki J. S., Reichek N., Fishman A. P. Long-term vasodilator therapy with trimazosin in chronic cardiac failure. N Engl J Med. 1980 Jul 31;303(5):242–250. doi: 10.1056/NEJM198007313030502. [DOI] [PubMed] [Google Scholar]
  73. Wilson J. R., Schwartz J. S., Sutton M. S., Ferraro N., Horowitz L. N., Reichek N., Josephson M. E. Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol. 1983 Sep;2(3):403–410. doi: 10.1016/s0735-1097(83)80265-4. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES